Allosteric interactions via the orthosteric ligand binding sites in a constitutive G-protein-coupled receptor homodimer

被引:2
作者
Kukkonen, Jyrki P. [1 ,2 ]
机构
[1] Univ Helsinki, Fac Med, Inst Biomed, Dept Pharmacol, POB 63, FI-00014 Helsinki, Finland
[2] Univ Helsinki, Fac Med, Inst Biomed, Dept Physiol, POB 63, FI-00014 Helsinki, Finland
关键词
G-protein-coupled receptor; Receptor dimerization; Receptor theory; Allosteric modulation; Mathematical modeling; OREXIN-A; OX1; MODEL; COOPERATIVITY; MODULATORS;
D O I
10.1016/j.phrs.2020.105116
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
I interpret some recent data to indicate that co-operative effects take place between the (identical) orthosteric binding sites in a G-protein-coupled receptor dimer. In the current study, the reasonability of this concept was tested by creating a mathematical model. The model is composed of a symmetrical constitutive receptor dimer in which the protomers are able to affect each other allosterically, and it includes binding, receptor activation and signal amplification steps. The model was utilized for analyses of previous data as well as simulations of predicted behaviour. The model demonstrates the behaviour stated in the hypotheses, i.e. even an apparently neutral receptor ligand can allosterically affect agonist binding or receptor activation by binding to the normal orthosteric ligand binding site. Therewith the speculated allosteric action originating from the orthosteric binding site of the dimeric receptor is a realistic possibility. The results of the simulations and curve fitting constitute a reasonable starting point for further studies, and the model can be utilized to design meaningful experiments to investigate these questions.
引用
收藏
页数:9
相关论文
共 44 条
[1]   Probing the existence of g protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding [J].
Albizu, Laura ;
Balestre, Marie-Noelle ;
Breton, Christophe ;
Pin, Jean-Philippe ;
Manning, Maurice ;
Mouillac, Bernard ;
Barberis, Claude ;
Durroux, Thierry .
MOLECULAR PHARMACOLOGY, 2006, 70 (05) :1783-1791
[2]   Distinct recognition of OX1 and OX2 receptors by orexin peptides [J].
Ammoun, S ;
Holmqvist, T ;
Shariatmadari, R ;
Oonk, HB ;
Detheux, M ;
Parmentier, M ;
Åkerman, KEO ;
Kukkonen, JP .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (02) :507-514
[3]   Rhodopsin-transducin interface: Studies with conformationally constrained peptides [J].
Arimoto, R ;
Kisselev, OG ;
Makara, GM ;
Marshall, GR .
BIOPHYSICAL JOURNAL, 2001, 81 (06) :3285-3293
[4]   Dopamine D2 receptor dimer formation -: Evidence from ligand binding [J].
Armstrong, D ;
Strange, PG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) :22621-22629
[5]   G protein-coupled receptor allosterism and complexing [J].
Christopoulos, A ;
Kenakin, T .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :323-374
[6]   NanoBRET: The Bright Future of Proximity-Based Assays [J].
Dale, Natasha C. ;
Johnstone, Elizabeth K. M. ;
White, Carl W. ;
Pfleger, Kevin D. G. .
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2019, 7 (MAR)
[7]   Structure-activity analysis of truncated orexin-A analogues at the orexin-1 receptor [J].
Darker, JG ;
Porter, RA ;
Eggleston, DS ;
Smart, D ;
Brough, SJ ;
Sabido-David, C ;
Jerman, JC .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (05) :737-740
[8]   AN ALLOSTERIC MODEL FOR BENZODIAZEPINE RECEPTOR FUNCTION [J].
EHLERT, FJ ;
ROESKE, WR ;
GEE, KW ;
YAMAMURA, HI .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (16) :2375-2383
[9]   Contribution of heteromerization to G protein-coupled receptor function [J].
Gaitonde, Supriya A. ;
Gonzalez-Maeso, Javier .
CURRENT OPINION IN PHARMACOLOGY, 2017, 32 :23-31
[10]   Truncated Orexin Peptides: Structure-Activity Relationship Studies [J].
German, Nadezhda A. ;
Decker, Ann M. ;
Gilmour, Brian P. ;
Thomas, Brian F. ;
Zhang, Yanan .
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (12) :1224-1227